Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Matloub · SciRah

Researcher profile · Semantic Scholar

Y. Matloub

Share profile

Y. Matloub — researcher profile on SciRah

h-index: 20
Works: 49
Citations: 1,897

Most-cited papers

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response or intolerance to imatinib
N. Shah, Dong-Wook Kim, H. Kantarjian, P. Rousselot +9 more
2010Haematologica251 citations Open access
Semantic Scholar
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
R. Egler, S. Ahuja, Y. Matloub
2016Journal of Pharmacology and Pharmacotherapeutics231 citations Open access
Semantic Scholar
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.
K. Maloney, M. Devidas, Cindy Y. Wang, L. Mattano +16 more
2019Journal of Clinical Oncology161 citations Open access
Semantic Scholar
Dasatinib 100 mg Once Daily Minimizes the Occurrence of Pleural Effusion in Patients With Chronic Myeloid Leukemia in Chronic Phase and Efficacy Is Unaffected in Patients who Develop Pleural Effusion
K. Porkka, H. Khoury, R. Paquette, Y. Matloub +2 more
2010Cancer158 citations Open access
Semantic Scholar
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Y. Matloub, B. Bostrom, S. Hunger, L. Stork +15 more
2011Blood141 citations Open access
Semantic Scholar
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Y. Matloub, Susan J. Lindemulder, P. Gaynon, H. Sather +12 more
2006Blood122 citations Open access
Semantic Scholar
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
Wei-Li Sun, J. Malvar, R. Sposto, A. Verma +26 more
2018Leukemia114 citations Open access
Semantic Scholar
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
L. Stork, Y. Matloub, E. Broxson, L. Mei +8 more
2010Blood94 citations Open access
Semantic Scholar
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study
S. Rheingold, D. Bhojwani, Ling-Yun Ji, Xinxin Xu +26 more
2024Leukemia79 citations Open access
Semantic Scholar
Staged informed consent for a randomized clinical trial in childhood leukemia: Impact on the consent process
A. Angiolillo, Christian M Simon, E. Kodish, Beverly J. Lange +3 more
2004Pediatric Blood & Cancer55 citations
Semantic Scholar
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
A. Pearson, Elly Barry, Y. Mossé, Franca Ligas +40 more
2021European Journal of Cancer47 citations Open access
Semantic Scholar
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331
L. Mattano, M. Devidas, K. Maloney, Cindy Y. Wang +16 more
2021Journal of Clinical Oncology36 citations Open access
Semantic Scholar
Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report from the Children’s Oncology Group
K. Meeske, Ling-Yun Ji, David R. Freyer, P. Gaynon +7 more
2015Pediatric Blood & Cancer36 citations Open access
Semantic Scholar
IN UTERO ENGRAFTMENT OF FULLY H‐2-INCOMPATIBLE VERSUS CONGENIC ADULT BONE MARROW TRANSFERRED INTO NONANEMIC OR ANEMIC MURINE FETAL RECIPIENTS
K. Howson‐Jan, Y. Matloub, D. Vallera, B. Blazar
1993Transplantation36 citations
Semantic Scholar
Is There a Potential Role for Serum Cardiac Troponin I as a Marker for Myocardial Dysfunction in Pediatric Patients Receiving Anthracycline-Based Therapy? A Pilot Study
P. Mathew, W. Suarez, K. Kip, E. Bayar +3 more
2001Cancer Investigation33 citations
Semantic Scholar
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
A. Pearson, C. Rossig, C. Mackall, N. Shah +50 more
2021European Journal of Cancer32 citations Open access
Semantic Scholar
Dasatinib Dose-Optimization in Chronic Phase Chronic Myeloid Leukemia (CML-CP): Two-Year Data from CA180-034 Show Equivalent Long-Term Efficacy and Improved Safety with 100 Mg Once Daily Dose
N. Shah, Dong-Wook Kim, H. Kantarjian, P. Rousselot +6 more
200826 citations
Semantic Scholar
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.
Y. Matloub, K. Rabin, Ling-Yun Ji, M. Devidas +11 more
2019Blood Advances25 citations Open access
Semantic Scholar
Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations
M. Müller, J. Cortes, Dong-Wook Kim, B. Druker +6 more
200822 citations
Semantic Scholar
Outcome of children with standard-risk T-lineage acute lymphoblastic leukemia – comparison among different treatment strategies
Y. Matloub, L. Stork, B. Asselin, Stephen P. Hunger +11 more
2015Pediatric Blood & Cancer20 citations Open access
Semantic Scholar
Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331
L. Mattano, M. Devidas, Alison M. Friedmann, E. Raetz +15 more
201420 citations Open access
Semantic Scholar
Antithymocyte globulin, cyclosporine, and prednisone for the treatment of severe aplastic anemia in children. A pilot study.
Y. Matloub, B. Bostrom, B. Golembe, J. Priest +1 more
1994American Journal Of Pediatric Hematology/Oncology20 citations
Semantic Scholar
Double Delayed Intensification (DDI) Is Equivalent to Single DI (SDI) in Children with National Cancer Institute (NCI) Standard-Risk Acute Lymphoblastic Leukemia (SR-ALL) Treated on Children’s Cancer Group (CCG) Clinical Trial 1991 (CCG-1991).
Y. Matloub, A. Angiolillo, B. Bostrom, S. Hunger +5 more
200619 citations
Semantic Scholar
Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children’s Oncology Group Study 1991
Y. Matloub, B. Bostrom, S. Hunger, A. Angiolillo +11 more
200816 citations
Semantic Scholar
Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic Leukemia at Children's Hospitals in the United States
Ajay Gupta, Rahul Damania, Ravi Talati, M. O'Riordan +2 more
2021Journal of Adolescent and Young Adult Oncology12 citations
Semantic Scholar
Epstein-Barr Virus-associated Mucocutaneous Ulcer in a Patient With T-Cell Acute Lymphoblastic Leukemia: Importance of Accurate Diagnosis and Conservative Management.
A. Vatsayan, Ashish O. Gupta, S. Ahuja, R. Egler +2 more
2017Journal of pediatric hematology/oncology12 citations
Semantic Scholar
2018 ASPHO ABSTRACTS
Aspho Abstracts, Kelly Maloney, M. Devidas, L. Mattano +17 more
2018Pediatric Blood & Cancer10 citations Open access
Semantic Scholar
#672 Oral 6‐thioguanine (TG) causes relatively mild and reversible hepatic venoocclusive disease (VOD)
L. Stork, G. Erdmaru, P. Adamson, B. Bostrom +8 more
199810 citations
Semantic Scholar
Prevalence of T315I, Dasatinib-Specific Resistant Mutations (F317L, V299L, and T315A), and Nilotinib-Specific Resistant Mutations (P-loop and F359) at the Time of Imatinib Resistance in Chronic-Phase Chronic Myeloid Leukemia (CP-CML).
M. Deininger, M. Mauro, Y. Matloub, R. Sinha +3 more
20089 citations
Semantic Scholar
Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium.
C. Zwaan, C. Rizzari, V. V. D. van der Velden, B. Beverloo +8 more
20089 citations
Semantic Scholar
Dasatinib Is Well-Tolerated and Efficacious in Imatinib-Intolerant Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML).
H. Khoury, M. Mauro, Y. Matloub, Tai-Tsang Chen +2 more
20098 citations
Semantic Scholar
PEDIATRIC CASE OF THE DAY
R. Coombs, E. Bayar, Y. Matloub, M. E. Velasco
19998 citations
Semantic Scholar
Dasatinib 100 Mg Once Daily (QD) Maintains Long-Term Efficacy and Minimizes the Occurrence of Pleural Effusion: An Analysis of 24-Month Data in Patients with Resistance, Suboptimal Response, or Intolerance to Imatinib (CA180-034).
K. Porkka, H. Khoury, R. Paquette, Y. Matloub +3 more
20085 citations
Semantic Scholar
Outcome of Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Standard Risk (SR) Features: Results of CCG-1952, CCG-1991 and POG 9404.
Y. Matloub, B. Asselin, L. Stork, M. Devidas +4 more
20044 citations
Semantic Scholar
Augmented Berlin-Frankfurt-Muenster (ABFM) regimen for children with standard-risk acute lymphoblastic leukemia (SR-ALL) and slow early response (SER)
Y. Matloub, A. Angiolillo, B. Bostrom, L. Stork +6 more
20073 citations
Semantic Scholar
Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.
Ashish O. Gupta, Rasmi Palassery, H. Meyerson, S. Ahuja +1 more
2019Journal of pediatric hematology/oncology2 citations
Semantic Scholar
Children with Down Syndrome (DS) and NCI Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Have a Superior Five-Year Event-Free Survival (EFS) When Treated with Escalating Intravenous Methotrexate on the Children's Cancer Group (CCG) Study 1991
Y. Matloub, B. Bostrom, S. Hunger, A. Angiolillo +8 more
20102 citations
Semantic Scholar
The Vast Majority of CML-CP Patients Treated with Dasatinib (70 mg BID) Who Progress after Long-Term Follow-up (24 mo) Remain in Chronic-Phase
J. Cortes, M. Mauro, S. O'Brien, G. Borthakur +5 more
20082 citations
Semantic Scholar
Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.
P. Gaynon, B. Camitta, Y. Matloub, P. Martin +7 more
20072 citations
Semantic Scholar
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Y. Matloub, L. Gore, Mignon Loh, C. Pui +6 more
2020Blood1 citations Open access
Semantic Scholar
Eltrombopag Eliminates Transfusion Requirements in a Patient with Fanconi Anemia
Ashish O. Gupta, Rasmi Palassery, S. Ahuja, R. Egler +1 more
20161 citations Open access
Semantic Scholar
Children with NCI Standard Risk Acute Lymphoblastic Leukemia (ALL) and TEL-AML1 or Favorable Chromosome Trisomies Are Almost Certain to Be Cured with Graduated Intensity Therapy: Results of the CCG - 1991 Study.
Y. Matloub, B. Bostrom, A. Angiolillo, M. Devidas +8 more
20091 citations
Semantic Scholar
Bone Marrow (BM) Minimal Residual Disease (MRD) at End of Induction and Interim Maintenance Is Highly Predictive of Outcome in Children with Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Treated on the Children’s Oncology Group Study 1991
Y. Matloub, P. Gaynon, S. Jayabose, B. Bostrom +8 more
20081 citations
Semantic Scholar
Cerebrospinal Fluid (CSF) Proteomics in Children with Acute Lymphoblastic Leukemia (ALL).
R. Trueworthy, L. Stork, Yan-Ping Zhong, S. Pine +4 more
20061 citations
Semantic Scholar
Pediatric case of the day. Ewing sarcoma of the rib with intraspinal extension.
R. Coombs, E. Bayar, Y. Matloub, M. E. Velasco
1999Radiographics1 citations
Semantic Scholar
ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or With T315I Mutation.
Lia Gore, Mignon Loh, C. Pui, Y. Matloub +6 more
2022Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
ALL-167: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Relapsed, Resistant, or Intolerant Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) or Have the T315I Mutation
L. Gore, Mignon Loh, C. Pui, M. Hanley +6 more
20210 citations
Semantic Scholar
Dasatinib Is Associated with Rapid and Durable Complete Hematologic Responses in Patients with Chronic-Phase Chronic Myeloid Leukemia (CPCML).
De-Long Liu, Y. Matloub, J. Mukhopadhyay, David R. Liu +1 more
20080 citations
Semantic Scholar
#604 Methotrexate induced leukoencephalopathy, by MRI‐an uncommon finding?
T. Karolyi, P. Mathew, R. Brinker, E. Bayar +3 more
19980 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Gaynon×16
Invite
P. Gaynon — researcher profile on SciRah
M. Devidas×14
Invite
M. Devidas — researcher profile on SciRah
N. Heerema×13
Invite
N. Heerema — researcher profile on SciRah
L. Stork×12
Invite
L. Stork — researcher profile on SciRah

×12

Invite

S. Hunger — researcher profile on SciRah

Invite

W. Carroll — researcher profile on SciRah

Invite

N. Winick — researcher profile on SciRah

Invite

H. Sather — researcher profile on SciRah

Invite

B. Bostrom — researcher profile on SciRah

A. Angiolillo×9

Invite

A. Angiolillo — researcher profile on SciRah

J. Gastier-Foster×8

Invite

J. Gastier-Foster — researcher profile on SciRah

Invite

J. Nachman — researcher profile on SciRah